Cryptotanshinone: A review of its pharmacology activities and molecular mechanisms
Authors:
- 1 September 2020
- journal article
- review article
- Published by Elsevier in Fitoterapia
- Vol. 145, 104633
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81573537, 81973416)
This publication has 123 references indexed in Scilit:
- Tanshinone IIA and Cryptotanshinone Prevent Mitochondrial Dysfunction in Hypoxia-Induced H9c2 Cells: Association to Mitochondrial ROS, Intracellular Nitric Oxide, and Calcium LevelsEvidence-Based Complementary and Alternative Medicine, 2013
- Apoptosis Induced by Tanshinone IIA and Cryptotanshinone Is Mediated by Distinct JAK/STAT3/5 and SHP1/2 Signaling in Chronic Myeloid Leukemia K562 CellsEvidence-Based Complementary and Alternative Medicine, 2013
- Inhibition of Hypoxia Inducible Factor Alpha and Astrocyte-Elevated Gene-1 Mediates Cryptotanshinone Exerted Antitumor Activity in Hypoxic PC-3 CellsEvidence-Based Complementary and Alternative Medicine, 2012
- Cryptotanshinone Activates p38/JNK and Inhibits Erk1/2 Leading to Caspase-Independent Cell Death in Tumor CellsCancer Prevention Research, 2012
- Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cellsCancer Letters, 2012
- Cryptotanshinone induces ER stress-mediated apoptosis in HepG2 and MCF7 cellsApoptosis, 2011
- The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cellsThe Prostate, 2011
- Cryptotanshinone enhances TNF-α-induced apoptosis in chronic myeloid leukemia KBM-5 cellsApoptosis, 2011
- Diterpenoid Tanshinones and Phenolic Acids from Cultured Hairy Roots of Salvia miltiorrhiza Bunge and Their Antimicrobial ActivitiesMolecules, 2011
- Cryptotanshinone has diverse effects on cell cycle events in melanoma cell lines with different metastatic capacityCancer Chemotherapy and Pharmacology, 2010